NCT05791084

Brief Summary

To examine the effect of a preparatory digital tool including a new instruction for deep inspiration breath hold (DIBH), before start of radiation therapy in women diagnosed with left sided breast cancer, compared with usual care.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
160

participants targeted

Target at P75+ for not_applicable

Timeline
35mo left

Started Sep 2023

Longer than P75 for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress48%
Sep 2023Mar 2029

First Submitted

Initial submission to the registry

February 22, 2023

Completed
1 month until next milestone

First Posted

Study publicly available on registry

March 30, 2023

Completed
5 months until next milestone

Study Start

First participant enrolled

September 1, 2023

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2024

Completed
4.5 years until next milestone

Study Completion

Last participant's last visit for all outcomes

March 30, 2029

Expected
Last Updated

March 30, 2023

Status Verified

March 1, 2023

Enrollment Period

1.1 years

First QC Date

February 22, 2023

Last Update Submit

March 16, 2023

Conditions

Keywords

DIBHRCTradiotherapymobile applicationdistress

Outcome Measures

Primary Outcomes (5)

  • Distress (DIS-A)

    The Distress Thermometer (DT) was developed as a simple tool to effectively screen for symptoms of distress. The instrument is a self-reported tool using a 0-to-10 rating scale, where 0 is no distress and 10 the worst distress.

    Time 1, baseline at randomisation/inclusion

  • Distress (DIS-A)

    The Distress Thermometer (DT) was developed as a simple tool to effectively screen for symptoms of distress. The instrument is a self-reported tool using a 0-to-10 rating scale, where 0 is no distress and 10 the worst distress.

    time 2, at CT-planning visit one week

  • Distress (DIS-A)

    The Distress Thermometer (DT) was developed as a simple tool to effectively screen for symptoms of distress. The instrument is a self-reported tool using a 0-to-10 rating scale, where 0 is no distress and 10 the worst distress.

    time 3, 3 weeks post RT

  • Distress (DIS-A)

    The Distress Thermometer (DT) was developed as a simple tool to effectively screen for symptoms of distress. The instrument is a self-reported tool using a 0-to-10 rating scale, where 0 is no distress and 10 the worst distress.

    time 4, 6 month post RT

  • Distress (DIS-A)

    The Distress Thermometer (DT) was developed as a simple tool to effectively screen for symptoms of distress. The instrument is a self-reported tool using a 0-to-10 rating scale, where 0 is no distress and 10 the worst distress.

    time 5, 5 years after RT

Secondary Outcomes (6)

  • HRQoL and Health economic (EQ-5D-5L)

    at baseline when inclusion/randomisation

  • HRQoL and Health economic (EQ-5D-5L)

    5 years post RT

  • e-HL (eHLQ)

    at baseline when inclusion/randomisation

  • Communicative, critical and functional HL

    at baseline when inclusion/randomisation

  • Preparedness(PCSQ-24)

    at CT planning visit, one week

  • +1 more secondary outcomes

Other Outcomes (19)

  • Logged data from the CT machine

    at Ct planning visit, one week

  • Logged data from the CT machine

    at Ct planning visit, one week

  • Data from the journal

    at Ct planning visit, one week

  • +16 more other outcomes

Study Arms (2)

A=Control group who receives customary information prior to RT with DIBH.

NO INTERVENTION

Usual care and information before start of radiotherapy with DIBH.

B=Intervention group usual care and the DIBH-App to practice at-home before RT with DIBH.

EXPERIMENTAL

Usual care and information and a mobile application with breathing instructions and a sensor to attach around the chest. To be able to train at home before radiotherapy with DIBH starts.

Other: mobile application with breathing instructions and a sensor to attach around the chest. To be able to train at home before radiotherapy with DIBH starts.

Interventions

The DIBH-App consists of 1) a mobile application that patients download to their own smart mobile phone, and 2) associated stretch-sensors that are attached around the chest and connected to the mobile phone via Bluetooth. Visually, the graphics is similar to the software used for DIBH in the RT department. Coaching takes place through instructional videos, text, and audio recordings (Image 2). The following information will be recorded and stored: date and time of practice, outcome of each session (including sensor data and calibration parameters), and user behavior within the application (such as screen visits, FAQ sections viewed, and key button presses).

B=Intervention group usual care and the DIBH-App to practice at-home before RT with DIBH.

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • patients \> 18 years of age
  • with a left-sided breast cancer diagnosis or DCIS
  • who are to receive RT with DIBH technology
  • with curative intention
  • preparatory CT visit minimum 7 days to a maximum of 4 weeks
  • able to speak and understand good enough Swedish to be able to assimilate content in the mobile app and answer surveys and interview questions
  • have access to a smart mobile phone.

You may not qualify if:

  • patients receiving palliative RT or neoadjuvant chemotherap
  • Planning CT starting \< 7 days
  • people with some form of orthopedic, rheumatological or neurological injury or disease that limits the possibility of carrying out the intervention.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Officials

  • maria Brovall, ass prof

    Jonkoping University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

maria Brovall, ass prof

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: RCT with an intervention and control group
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
associated professor

Study Record Dates

First Submitted

February 22, 2023

First Posted

March 30, 2023

Study Start

September 1, 2023

Primary Completion

September 30, 2024

Study Completion (Estimated)

March 30, 2029

Last Updated

March 30, 2023

Record last verified: 2023-03